RescueDoppler- a Disruptive Ultrasound Solution for Improved Outcome After Cardiac Arrest.

Launched by NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY · Sep 16, 2024

Keywords

ClinConnect Summary

The RescueDoppler trial is studying a new, hands-free ultrasound device designed to help healthcare providers monitor blood flow in the neck during emergencies like cardiac arrest. This innovative system can quickly tell if there is a pulse, which is crucial for deciding the next steps in treatment. The trial aims to see how well this device works both before and after patients arrive at the hospital.

To participate in this study, individuals need to be 18 years or older and must be experiencing a sudden cardiac arrest, which means their heart has stopped beating suddenly. However, people who have a "do-not-resuscitate" order or have serious injuries that prevent the device from being used won't be eligible. Participants will have their blood flow monitored using the RescueDoppler device, and the study will help determine if it can improve care in such critical situations.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female, aged 18 years or older. Subjects experiencing a sudden cardiac arrest, either pre-hospital or in-hospital. Sudden cardiac arrest is defined as the abrupt loss of heart function, breathing, and consciousness.
• Exclusion Criteria:
• • Subjects where resuscitation is not continued after the initial application of RescueDoppler or resuscitation efforts are halted due to a do-not-resuscitate order.
• • Subjects deemed unable to comply with the study requirements as determined by the Investigator.
• • Subjects with extensive trauma injuries that prevent proper attachment of the RescueDoppler patch.